Nicaragua vs Yemen: Incidence of tuberculosis
Incidence of tuberculosis over time
- Nicaragua
- Yemen
How they compare
Nicaragua currently reports 43 per 100,000 people against 40 per 100,000 people in Yemen, a difference of 3 per 100,000 people.
That makes Nicaragua's figure about 1.1 times Yemen's.
Across all 25 years both countries report, Nicaragua has been ahead every year.
Nicaragua ranks 104th and Yemen ranks 106th of 208 countries.
Nicaragua has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Nicaragua | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.6 per 100,000 people | 62.4 per 100,000 people | 29.2 per 100,000 people | Nicaragua |
| 2010s | 61.2 per 100,000 people | 41.6 per 100,000 people | 19.6 per 100,000 people | Nicaragua |
| 2020s | 45 per 100,000 people | 36.2 per 100,000 people | 8.8 per 100,000 people | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Nicaragua or Yemen?
- Nicaragua, at 43 per 100,000 people against 40 per 100,000 people in Yemen as of 2024.
- What is the difference in incidence of tuberculosis between Nicaragua and Yemen?
- 3 per 100,000 people, with Nicaragua ahead.
- How many years of comparable data are there for Nicaragua and Yemen?
- 25 years are reported by both, from 2000 to 2024.
- How do Nicaragua and Yemen rank globally for incidence of tuberculosis?
- Nicaragua ranks 104th and Yemen ranks 106th of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.